Nanoviricides, Inc.
NNVC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001379006
No open-market purchases or sales by Nanoviricides, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $3.27M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Nanoviricides, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 29 | 34 | +5 |
| Shares | 1.19M | 1.34M | +148.9K (+12.5%) |
| Value | $1.38M | $2.31M | +$925.8K (+66.9%) |
New holders (9)
Institutions that held Nanoviricides, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Integrated Wealth Concepts LLC | 36,835 | $63.4K | 0.00% |
| Susquehanna International Group, LLP | 22,356 | $38.5K | 0.00% |
| Moss Adams Wealth Advisors LLC | 15,000 | $25.8K | 0.00% |
| Verition Fund Management LLC | 13,003 | $22.4K | 0.00% |
| Virtu Financial LLC | 11,140 | $19.0K | 0.00% |
| Activest Wealth Management | 1,000 | $1.72K | 0.00% |
| TD Waterhouse Canada Inc. | 260 | $473 | 0.00% |
| Parallel Advisors, LLC | 157 | $270 | 0.00% |
| Ashton Thomas Private Wealth, LLC | 58 | $100 | 0.00% |
Sold out (4)
Institutions that held Nanoviricides, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Citadel Advisors LLC | 21,489 | $24.9K |
| UBS Group AG | 422 | $490 |
| Wells Fargo & Company | 135 | $157 |
| Simplex Trading, LLC | 136 | $0 |